Appointments
Prilenia Therapeutics B.V. has announced the appointment of Anne Sullivan as Chief Business Officer. Sullivan will lead all strategic collaboration activities at the clinical stage biotechnology company, which develops novel therapeutics to slow the progression of neurodegenerative and neurodevelopmental disorders. Dr Michael R. Hayden, CEO and Founder of Prilenia, said: “As Prilenia prepares for key [...]
SP Industries, Inc has announced the appointment of Kevin Sutherby as its new President. The company is a global provider of fill-finish drug manufacturing solutions, lyophilizers and laboratory equipment and supplies. Sutherby has more than years’ experience leading global manufacturing companies, including senior leadership positions at Danaher and Fortive and most recently as Senior Vice [...]
Darren Goode, who previously led health tech company Elvie to become a $26m global brand, will now turn his efforts to innovative, home fertility femtech firm, Béa Fertility… A former global chief marketing officer at Elvie has been appointed as a leading advisor at femtech startup Béa Fertility - where he plans to help the [...]
Biotechnology company Aspect Biosystems has announce the appointment of three new members to its Board of Directors: Dr Nancy Krieger, Dr Don Haut and Dr Devyn Smith. The company develops bioprinted tissue therapeutics to transform how diseases are treated. Dr Don Haut is currently the CEO of discovery-stage, non-viral gene therapy company Carmine Therapeutics. Originally [...]
General Electric (GE) has announced the first Board of Directors for its independent healthcare spinoff, GE HealthCare. The company is set to be created following a spinoff slated for the first week of January 2023, subject to board approval. Lawrence Culp, Jr., Chairman and CEO, GE, and CEO, GE Aerospace, will serve as Non-Executive Chairman [...]
Biotechnology company Nutcracker Therapeutics has appointed Rob Schott, M.D., M.P.H, F.A.C.C., as Chief Medical Officer. The California-based company develops RNA therapies through its proprietary technology platform, NTX-0250. Dr Schott will guide the clinical advancement of the company’s oncology pipeline. Igor Khandros, Ph.D., cofounder and Chief Executive Officer of Nutcracker Therapeutics, said: “Rob’s extensive background, which [...]
B-Secur has announced the appointment of Mark Bogart as Senior Vice President (SVP) of U.S. Healthcare. Bogart will identify, develop and build long-term agreements with medical device and digital health companies and cultivate and manage customer relationships with existing partners. The new SVP will also focus on delivering the company’s medical strategy for its newly [...]
Health outcomes company MOBE has announced the appointments of Mike Ott as Chief Executive Officer and Kurt Cegielski as Chief Commercial Officer—Health Plans. MOBE combines data and analytics to identify individuals whose health needs are increasing while their health is not improving. Mark Evenstad, Founder and Chairman of MOBE, said: “As senior executives in the [...]
Fully integrated gene therapy company Kriya Therapeutics has appointed Pedro Huertas, M.D., Ph.D., as Chief Medical Officer of its Rare Disease Division. Dr Huertas will be responsible for directing and executing the companies clinical, medical and scientific plans in order to advance its rare disease pipeline. Dr Huertas has three decades of experiences in advancing [...]
Cell rejuvenation company Turn Biotechnologies has announced the appointment of co-founder Vittorio Sebastiano, PhD as head of research. The company develops novel mRNA medicines to cure untreatable, age-related diseases. Sebastiano led the development of Turn Bio’s ERA platform which produces tailored protein cocktails to rejuvenate cells. Sebastiano, who assumes the new role this month, has [...]
